Poland Market Access Director: Value & Payer Strategy

Revolution Medicines, Inc.; Polska; On-site; PLN 300,000 - 420,000; Full time

Job summary

Revolution Medicines, Inc. is seeking a Market Access Director for Poland to define and execute the country access strategy.

You will lead reimbursement efforts, HTA filings, and pricing negotiations, engaging payers, HTA bodies, and authorities to enable timely access to innovative oncology therapies. You will collaborate with regulatory, medical affairs, and marketing teams to translate clinical and economic evidence into Poland-focused value communications and drive pricing strategy

Qualifications

• Lead Market Access and Reimbursement strategy for Poland launches.
• Prepare and submit HTA dossiers and pricing negotiations with payers.
• Translate clinical and economic evidence into Poland-focused value messaging.

Responsibilities

• Define and execute Poland market access strategy.
• Lead HTA filings and pricing negotiations with statutory payers.
• Collaborate with regulatory, medical affairs, and marketing teams.
• Develop pricing and value-based contracting models to speed reimbursement.
• Monitor health policy developments and payer environments for strategy input.
• Represent Market Access in Poland leadership meetings and cross-border strategy.

Skills

Market Access Leadership

HTA & Pricing

Stakeholder Engagement

Payer Negotiation

Health Policy Monitoring

Pricing Strategy

Cross-Functional Collaboration

Early Access Planning

EU & Regional Strategy

Market Access Analytics

Education

Advanced degree in Life Sciences/Pharm/HEOR

Job description

Revolution Medicines, Inc. is seeking a Market Access Director for Poland to define and execute the country access strategy.

You will lead reimbursement efforts, HTA filings, and pricing negotiations, engaging payers, HTA bodies, and authorities to enable timely access to innovative oncology therapies. You will collaborate with regulatory, medical affairs, and marketing teams to translate clinical and economic evidence into Poland-focused value communications and drive pricing strategy